Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal experiment design for practical parameter identifiability and model discrimination.

Mathematical biosciences·2026
Same author

Modeling Collective Cell Migration in a Data-Rich Age: Challenges and Opportunities for Data-Driven Modeling.

Cold Spring Harbor perspectives in biology·2026
Same author

A likelihood-based Bayesian inference framework for the calibration of and selection between stochastic velocity-jump models.

Journal of the Royal Society, Interface·2026
Same author

The influence of cell phenotype on collective cell invasion into the extracellular matrix.

Bulletin of mathematical biology·2025
Same author

Optimal experimental design for parameter estimation in the presence of observation noise.

Mathematical biosciences·2025
Same author

Mathematical modeling predicts novel mechanisms of stream confinement from Trail/Colec12/Dan in the collective migration of cranial neural crest cells.

Developmental dynamics : an official publication of the American Association of Anatomists·2025

Related Experiment Video

Updated: Sep 11, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

679

Optimal Control of Immune Checkpoint Inhibitor Therapy in a Heart-Tumour Model.

Solveig A van der Vegt1, Ruth E Baker1, Sarah L Waters2

  • 1Mathematical Institute, University of Oxford, Oxford, UK.

Bulletin of Mathematical Biology
|August 11, 2025
PubMed
Summary

Mathematical models for cancer therapy now include autoimmune myocarditis, a fatal side effect of immune checkpoint inhibitors (ICIs). This approach optimizes ICI dosing schedules by balancing treatment benefits against cardiac risks.

Keywords:
Autoimmune myocarditisImmune checkpoint inhibitorsOptimal controlTumour growth

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

679
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.1K

Area of Science:

  • Oncology
  • Immunology
  • Mathematical Biology

Background:

  • Immune checkpoint inhibitors (ICIs) are vital cancer therapies but can cause autoimmune myocarditis, a rare, fatal cardiac side effect.
  • Current mathematical models for cancer therapy optimization often exclude critical side effects like myocarditis.
  • This omission limits the ability to predict and mitigate treatment-related toxicities.

Purpose of the Study:

  • To develop a mathematical model integrating the effects of ICIs on both tumors and the heart.
  • To investigate the conditions leading to autoimmune myocarditis as a consequence of ICI therapy.
  • To design optimized ICI dosing schedules that balance therapeutic efficacy with cardiac safety.

Main Methods:

  • Developed a two-compartment mathematical model to simulate ICI impact on tumor and heart.
  • Employed an optimal control framework to determine dosing schedules.
  • Analyzed three distinct types of ICI therapy.

Main Results:

  • The model successfully incorporates the dual effects of ICIs on cancer and cardiac tissue.
  • Explicit inclusion of autoimmune myocarditis significantly alters predicted optimal dosing schedules.
  • Optimized schedules were designed to mitigate cardiac risks while maintaining therapeutic benefits.

Conclusions:

  • Integrating side effects like autoimmune myocarditis into mathematical models is crucial for safe and effective cancer therapy.
  • A holistic approach considering both efficacy and toxicity is essential for optimizing ICI treatment regimens.
  • This modeling framework provides a basis for personalized cancer treatment strategies that account for potential adverse events.